IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MORELLO, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.184
AS - Asia 2.829
EU - Europa 2.762
SA - Sud America 517
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 89
OC - Oceania 13
Totale 11.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.946
SG - Singapore 1.137
IT - Italia 1.062
CN - Cina 667
BR - Brasile 413
PL - Polonia 315
DE - Germania 280
HK - Hong Kong 255
FI - Finlandia 219
VN - Vietnam 210
BD - Bangladesh 178
UA - Ucraina 167
FR - Francia 153
GB - Regno Unito 137
RU - Federazione Russa 122
CA - Canada 115
IN - India 86
TR - Turchia 81
IE - Irlanda 51
NL - Olanda 51
SE - Svezia 46
MX - Messico 40
ES - Italia 33
JP - Giappone 32
CZ - Repubblica Ceca 31
IQ - Iraq 28
AR - Argentina 26
ID - Indonesia 26
ZA - Sudafrica 23
BE - Belgio 21
EC - Ecuador 20
CO - Colombia 18
TH - Thailandia 15
VE - Venezuela 14
AT - Austria 13
MY - Malesia 13
PK - Pakistan 13
AU - Australia 12
GT - Guatemala 12
MA - Marocco 12
SV - El Salvador 12
EG - Egitto 11
IL - Israele 11
JM - Giamaica 11
CR - Costa Rica 10
ET - Etiopia 10
PT - Portogallo 10
GR - Grecia 9
TT - Trinidad e Tobago 9
PY - Paraguay 8
SA - Arabia Saudita 8
LT - Lituania 7
PH - Filippine 7
AZ - Azerbaigian 6
DZ - Algeria 6
KZ - Kazakistan 6
NI - Nicaragua 6
PE - Perù 6
UY - Uruguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DK - Danimarca 5
GH - Ghana 5
HN - Honduras 5
IR - Iran 5
JO - Giordania 5
KE - Kenya 5
LK - Sri Lanka 5
PR - Porto Rico 5
CL - Cile 4
CW - ???statistics.table.value.countryCode.CW??? 4
HU - Ungheria 4
NO - Norvegia 4
NP - Nepal 4
SC - Seychelles 4
TW - Taiwan 4
GP - Guadalupe 3
KG - Kirghizistan 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TN - Tunisia 3
UG - Uganda 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
LV - Lettonia 2
MD - Moldavia 2
RO - Romania 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
Totale 11.387
Salva come PNG Salva come JPEG
Città #
Singapore 667
Ashburn 601
San Jose 476
Warsaw 304
Hong Kong 251
Fairfield 238
Council Bluffs 235
New York 212
The Dalles 185
Beijing 159
Brescia 154
Helsinki 154
Woodbridge 149
Chandler 139
Los Angeles 139
Jacksonville 126
Seattle 121
Munich 115
Milan 114
Houston 111
Dallas 110
Ann Arbor 109
Wilmington 94
Lauterbourg 81
Rome 79
Princeton 77
Des Moines 67
Cambridge 66
Santa Clara 66
Ho Chi Minh City 62
Columbus 57
Boardman 56
Istanbul 54
Dublin 49
São Paulo 49
Hanoi 46
San Francisco 45
Shanghai 45
Chicago 44
Turku 43
Buffalo 40
Toronto 35
Phoenix 34
Moscow 33
Naples 31
Orem 30
North Bergen 29
Redondo Beach 29
Brooklyn 26
London 26
Tokyo 26
Nanjing 25
Frankfurt am Main 24
Turin 24
Atlanta 22
Brno 22
Nuremberg 22
Charlotte 21
Chennai 20
Montreal 20
Brussels 19
Denver 19
Mexico City 19
Stockholm 18
Boston 17
Florence 16
Tianjin 16
Johannesburg 15
Poplar 15
Bari 14
Changsha 14
Pune 14
Verona 14
Amsterdam 13
Mumbai 13
San Diego 13
Baghdad 12
Lappeenranta 12
Newark 12
Paris 12
Guayaquil 11
Jinan 11
Manchester 11
San Salvador 11
Barlassina 10
Wroclaw 10
Addis Ababa 9
Brasília 9
Guatemala City 9
Haiphong 9
Pavia 9
Shenyang 9
Washington 9
Alessandria 8
Belo Horizonte 8
Bergamo 8
Bologna 8
Da Nang 8
Kuala Lumpur 8
Rio de Janeiro 8
Totale 6.968
Salva come PNG Salva come JPEG
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 305
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 300
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults 251
OUR FOOD, OUR HEALTH: NOURISHING BIODIVERSITY TO HEAL OURSELVES AND THE PLANET Slow Food’s Position Paper on Food and Health 241
Malnutrizione, valutazione nutrizionale e aspetti dietetici 236
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 216
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 210
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 206
Advances in CMV Management: A Single Center Real-Life Experience 187
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 179
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 178
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 175
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 174
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 173
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 172
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 167
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 166
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 164
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study 163
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 163
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 160
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 159
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 159
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 159
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 156
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 155
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 151
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 150
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 148
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 147
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 146
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 146
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 144
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 144
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 141
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 140
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 139
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 136
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 135
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 133
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. 131
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 131
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 130
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS 130
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. 129
P. aeruginosa bloodstream infections among hematological patients: an old or new question? 128
Nutritional strategies to improve VRE control 125
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 124
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 123
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 123
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 123
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 123
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 122
Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS) 122
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 122
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 120
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin's lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability 120
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 118
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 115
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group 115
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 112
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 110
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 109
RIC Allogeneic Transplantation Improves the Overall and Progression-Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLA-Typing and Donor Availability. 108
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 106
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 104
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 100
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 98
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 96
I diritti del malato 89
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 87
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 87
Aspetti Clinici della cGVHD polmonare 86
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 86
Superiority of RIC allogeneic transplantation over conventional treatment for HL patients relapsing after autologous transplantation: a GITMO retrospective study based on time of HLA-typing and donor availability. 83
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 78
Moving the Care Process in the in-Home Context: The Therapeutic Prescription 78
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 70
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 65
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 49
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 49
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 42
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 39
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 37
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission 28
Cytokine Release Syndrome after Haploidentical Transplantation is Associated with Improved Survival Without Increasing Transplant-Related Mortality 21
Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature 20
Correction: Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 (Cancers, (2025), 17, 20, (3278), 10.3390/cancers17203278) 16
The role of physical therapy across the transplant trajectory in allogeneic hematopoietic stem cell transplantation, a systematic review and clinical framework 16
Fluoroquinolone-Free Prophylaxis and Impact on Bacterial Infections, Resistance, and Survival in Allo-HSCT: 5-Year Follow-up of the BATMO Protocol (Best Anti-microbical Therapy Trapianto di Midollo Osseo) 15
Totale 11.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022283 0 0 0 0 11 33 16 32 18 64 28 81
2022/2023451 54 12 18 40 44 99 3 54 53 13 30 31
2023/2024675 40 16 55 38 34 156 28 26 118 9 17 138
2024/20252.054 41 54 24 188 178 165 135 132 323 181 350 283
2025/20264.794 357 419 289 577 483 404 803 245 322 446 233 216
2026/20271.444 232 230 294 667 21 0 0 0 0 0 0 0
Totale 11.532